Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting

Current Drug Discovery Technologies

Volumn 10, Issue 4, 2013, Pages 270-282

  Ravouru, Nagaraju ^a   Kondreddy, Pallavi ^a   Korakanchi, Deepthy ^a   Haritha, M ^a  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

BBB; Characterization; Ex vivo studies; Folic acid niosomes; Nasal delivery; Olfactory region; Optimization

Indexed keywords

CHOLESTEROL; FOLIC ACID; NIOSOME; POLYSORBATE 20; POLYSORBATE 80; SORBITAN LAURATE; SORBITAN OLEATE; SORBITAN STEARATE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN TARGETING; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUTION; ENTRAPMENT EFFICIENCY; MALE; NIOSOMAL NASAL DRUG DELIVERY SYSTEM; NONHUMAN; NOSE MUCOSA; OSMOTIC STRESS; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; RAT; TARGET ORGAN; VISCOSITY;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FOLIC ACID; LIPOSOMES; MALE; NASAL MUCOSA; OSMOTIC PRESSURE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SURFACE-ACTIVE AGENTS; VISCOSITY; VITAMIN B COMPLEX;

EID: 84892142829     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/15701638113109990031     Document Type: Article

References (37)

1. Paun JS, Bagada AA, Raval MK. Nasal Drug Delivery - As An Effective Tool For Brain Targeting - A Review. Int J Pharm and App Sci 2010.
2. Jadhav KR, Gambhire MN, Shaikh IM, Kadam VJ, Pisal SS. Nasal drug delivery system - factors affecting and applications. Curr Drug Therapy 2007; 2: 27-38.
3. Frey WH, Liu J, Chen X, Thorne RG, Fawcett JR, Ala TA. Delivery of 125I-NGF to the brain via the olfactory route. Drug Delivery 1997; 4: 87-92.
4. Chen XQ, Fawcett JR, Rahman YE, Ala TA, Frey WH. Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis 1998; 1: 35-44.
5. Frey WH, Thorne RG, Pronk G. Delivery of Insulin like growth factor-1 to the brain and spinal cord along olfactory and trigeminal pathways following intranasal administration: a noninvasive method for bypassing the blood brain barrier. Soc Neurosci Abstract 2000; 26: 1365-70.
6. Kucheryanu VG, Kryzhanovsky GN, Kudrin VS, Yurasov VV, Zhigaltsev IV. Intranasal fibroblast growth factors: delivery into the brain exerts antiparkinsonian effect in mice, in 26th Int. Symp on Controlled Release of Bioactive Materials (Controlled Release Society Inc., Boston MA,) 1999; 643.
7. Gozes I, Bardea A, Reshef A, et al. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci USA 1996; 93: 427-32.
8. Pietrowsky R, Struben C, Molle M, Fehm HL, Born J. Brain potential changes after intranasal administration vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans. Biol Psychiatry 1996; 39: 332-40.
9. Pietrowsky R, Thieman A, Kern W, Fehm HL, Born JA. A nosebrain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 1996; 21: 559-72.
10. Smolnik R, Molle M, Fehm HL, Born J. Brain potentials and attention after acute subchronic Intranasal administration of ACTH4-10 desacetyl-a-MSH in humans. Neuroendocrinol 1999; 70: 63-72.
11. Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, Born J. The melanocortin melanocyte-stimulating hormone/adrenocotropin (4-10) decreases body fat in humans. J Clin Endocrinol Metab 2001; 86: 1144-8.
12. Kern W, Born J, Schreiber H, Fehm HL. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 1999; 48: 557-63.
13. Chow HS, Chen Z, Matsuura GT. Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats. J Pharm Sci 1999; 88: 754-8.
14. Dahlin M, Bergman U, Jansson B, Bjork E, Brittebo E. Transfer of dopamine in the olfactory pathway following nasal administration in mice. Pharm Res 2000; 17: 737-42.
15. Anand KTC, David GFX, Umberkoman B, Saini KD. Uptake of radioradioactivity by body fluids and tissues in rhesus monkeys after intravenous injection or intranasal spray of tritium-labelled estradiol and progesterone. Curr Sci 1974; 43: 435-9.
16. Sakane T, Akizuki M, Yamashita S, Nadai T, Hashida M, Sezaki H. The transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J Pharm Pharmacol 1991; 43: 449-51.
17. Shi ZQ, Zhang QZ, Jiang XG. Enhancement of systemic and CNS delivery of meptazinol hydrochloride by intranasal administration to rats. Yao Xue Xue Bao 2005; 40(8): 754-7.
18. Talegaonkar S, Mishra PR. Intranasal delivery: An approach to bypass the blood brain barrier. Indian J Pharmacol 2004; 36(3): 140-7.
19. Rieder CR, Fricke D. Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology Neurology 2001; 57(9): 1742-3.
20. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55(11): 1449-55.
21. Subodh D, Amit J, Mehta SC, Pavan G, Sandeep J, Jagdish S. Niosomes: The ultimate drug carrier. Drug Invention Today 2010; 2(1): 72-77.
22. Uchegbu FI, Vyas PS. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998; 33: 172.
23. Mouzam MI, Dehghan MHG, Samina SM. Development and characterization of salmeterol xinafoate niosomes for nasal delivery. Int J Pharm Edu Res 2011; 45(2).
24. Srinivas S, Kumar YA, Hemanth A, Anitha M. Preparation and evaluation of niosomes containing Aceclofenac. DJNB. Vol.5, No 1, March 2010, P.249-254.
25. Kandasamy Ruckmani and Veintramuthu Sankar, Formulation and Optimization of Zidovudine Niosomes, AAPS PharmSciTech, Vol. 11, No. 3, September 2010 (# 2010) DOI: 10.1208/s12249-010-9480-2.
26. S. GayathriDevi, Venkatesh and N. Udupa. Niosomal sumatriptan succinate for nasal administration. Int. J. Pharm. Sci., October 25, 2010, IP:210.212.229. 196.
27. Hussain A, Dittert LW, Traboulsi A. Brain delivery of folic acid for the prevention of Alzheimer's disease and stroke. US: Patent 6; 2002. p. 369,058.
28. C.V.S. Subramanyam, Text book of physical pharmaceutics, 102- 104.
29. Tank Chintankumar J, Borkhataria Chetan H, Baria Ashok H, Patel Rakesh P, S. Tamizharasi, Dipen K. Sureja, Sandip D. Patel, Ghanshyam R. Parmar, Formulation and evaluation of aceclofenac Loaded maltodextrin based proniosome, Int J Chem Tech Res Vol.1, No.3, pp 567-573, July-Sept 2009.
30. Dakhara Sanjay L, Anajwala Chetan C, Singhal Nirav A, Selote Vidula S. Phospholipids and non-ionic surfactants containing niosome is far better than liposome as ophthalmic dosage form. J Pharm Res 2010; 3(10): 2488-91.
31. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/ niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001; 228: 43-52.
32. Kublik H, Vidgren MT. Nasal delivery systems and their effect on deposition and absorption. Adv Drug Deliv Rev 1998; 29: 157-77.
33. Uchegbu IF (1994) Some aspects of the niosomal delivery of doxorubicin. Ph. D. thesis. University of London, England.
34. Ahmed SG, Nahed DM, Samar M, Rania MH. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005; 306: 71-82.
35. Aarti Jagtap and Deepali Inamdar. Formulation and evaluation of niosomes entrapped Pentoxifylline using invivo bronchodilatory activity in Guinea pigs. Indian J Pharm Scl 2001; 63(1): 49-54.
36. Chein YW (1985) Transnasal systemic medications. Elsevier, Amsterdam/ Oxford/NY/Tokyo.
37. Dey S, Mahanti B, Mazumder B, et al. Nasal drug delivery: An approach of drug delivery through nasal route. Der Pharmacia Sinica 2011; 2 (3): 94-106.